APO Research
Talk to an analyst

APO RESEARCH · REPORT

Colloidal Gold Immunochromatography Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Colloidal Gold Immunochromatography Platform Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchColloidal Gold Immunochromatography Platform Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Colloidal Gold Immunochromatography Platform Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Colloidal Gold Immunochromatography Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Colloidal Gold Immunochromatography Platform Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Colloidal Gold Immunochromatography Platform Market Analysis and Forecast 2026-2032234 pages · $4,950 USD

Market perspective

The global Colloidal Gold Immunochromatography Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Colloidal Gold Immunochromatography Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Colloidal Gold Immunochromatography Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Colloidal Gold Immunochromatography Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Colloidal Gold Immunochromatography Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Colloidal Gold Immunochromatography Platform market include Abbott, Roche, Siemens Healthineers, BD, SD Biosensor, Abbott Rapid Diagnostics, QuidelOrtho, BioMerieux and Wondfo, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Colloidal Gold Immunochromatography Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Colloidal Gold Immunochromatography Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Colloidal Gold Immunochromatography Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Colloidal Gold Immunochromatography Platform market.

Colloidal Gold Immunochromatography Platform Segment by Company

Abbott

Roche

Siemens Healthineers

BD

SD Biosensor

Abbott Rapid Diagnostics

QuidelOrtho

BioMerieux

Wondfo

Celltrion

Biomerica

Orient Gene

Hotgen Biotech

Easy Diagnosis Biomedicine

Getein Biotech

Biology and Science

Boson Biotech

Beijing WANTAI

Colloidal Gold Immunochromatography Platform Segment by Type

Naked-Eye Card Reader Platform

Matching Reader Instrument Platform

Colloidal Gold Immunochromatography Platform Segment by Application

Medical Industry

Food Industry

Scientific Research Industry

Others

Colloidal Gold Immunochromatography Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Colloidal Gold Immunochromatography Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Colloidal Gold Immunochromatography Platform key companies, revenue, market share, and recent developments.

3. To split the Colloidal Gold Immunochromatography Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Colloidal Gold Immunochromatography Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Colloidal Gold Immunochromatography Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Colloidal Gold Immunochromatography Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colloidal Gold Immunochromatography Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Colloidal Gold Immunochromatography Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colloidal Gold Immunochromatography Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Colloidal Gold Immunochromatography Platform industry.

Chapter 3: Detailed analysis of Colloidal Gold Immunochromatography Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Colloidal Gold Immunochromatography Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Colloidal Gold Immunochromatography Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Colloidal Gold Immunochromatography Platform Industry Trends Table 2. Colloidal Gold Immunochromatography Platform Industry Drivers Table 3. Colloidal Gold Immunochromatography Platform Industry Opportunities and Challenges Table 4. Colloidal Gold Immunochromatography Platform Industry Restraints Table 5. Global Colloidal Gold Immunochromatography Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Colloidal Gold Immunochromatography Platform Revenue Share by Company (2021-2026) Table 7. Global Colloidal Gold Immunochromatography Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Colloidal Gold Immunochromatography Platform Key Company Manufacturing Base & Headquarters Table 9. Global Colloidal Gold Immunochromatography Platform Company, Product Type & Application Table 10. Global Colloidal Gold Immunochromatography Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Colloidal Gold Immunochromatography Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Naked-Eye Card Reader Platform Table 15. Significant Companies of Matching Reader Instrument Platform Table 16. Global Colloidal Gold Immunochromatography Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Colloidal Gold Immunochromatography Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Colloidal Gold Immunochromatography Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Colloidal Gold Immunochromatography Platform Sales Value Share by Type (2021-2026) Table 20. Global Colloidal Gold Immunochromatography Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Industry Table 22. Significant Companies of Food Industry Table 23. Significant Companies of Scientific Research Industry Table 24. Significant Companies of Others Table 25. Global Colloidal Gold Immunochromatography Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Colloidal Gold Immunochromatography Platform Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Colloidal Gold Immunochromatography Platform Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Colloidal Gold Immunochromatography Platform Sales Value Share by Application (2021-2026) Table 29. Global Colloidal Gold Immunochromatography Platform Sales Value Share by Application (2027-2032) Table 30. Global Colloidal Gold Immunochromatography Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Colloidal Gold Immunochromatography Platform Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Colloidal Gold Immunochromatography Platform Sales Value Share by Region (2021-2026) Table 33. Global Colloidal Gold Immunochromatography Platform Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Colloidal Gold Immunochromatography Platform Sales Value Share by Region (2027-2032) Table 35. Global Colloidal Gold Immunochromatography Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Colloidal Gold Immunochromatography Platform Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Colloidal Gold Immunochromatography Platform Sales Value Market Share by Country (2021-2026) Table 38. Global Colloidal Gold Immunochromatography Platform Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Colloidal Gold Immunochromatography Platform Sales Value Market Share by Country (2027-2032) Table 40. Abbott Company Information Table 41. Abbott Business Overview Table 42. Abbott Colloidal Gold Immunochromatography Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Abbott Colloidal Gold Immunochromatography Platform Product Portfolio Table 44. Abbott Recent Development Table 45. Roche Company Information Table 46. Roche Business Overview Table 47. Roche Colloidal Gold Immunochromatography Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Roche Colloidal Gold Immunochromatography Platform Product Portfolio Table 49. Roche Recent Development Table 50. Siemens Healthineers Company Information Table 51. Siemens Healthineers Business Overview Table 52. Siemens Healthineers Colloidal Gold Immunochromatography Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Siemens Healthineers Colloidal Gold Immunochromatography Platform Product Portfolio Table 54. Siemens Healthineers Recent Development Table 55. BD Company Information Table 56. BD Business Overview Table 57. BD Colloidal Gold Immunochromatography Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. BD Colloidal Gold Immunochromatography Platform Product Portfolio Table 59. BD Recent Development Table 60. SD Biosensor Company Information Table 61. SD Biosensor Business Overview Table 62. SD Biosensor Colloidal Gold Immunochromatography Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. SD Biosensor Colloidal Gold Immunochromatography Platform Product Portfolio Table 64. SD Biosensor Recent Development Table 65. Abbott Rapid Diagnostics Company Information Table 66. Abbott Rapid Diagnostics Business Overview Table 67. Abbott Rapid Diagnostics Colloidal Gold Immunochromatography Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Abbott Rapid Diagnostics Colloidal Gold Immunochromatography Platform Product Portfolio Table 69. Abbott Rapid Diagnostics Recent Development Table 70. QuidelOrtho Company Information Table 71. QuidelOrtho Business Overview Table 72. QuidelOrtho Colloidal Gold Immunochromatography Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. QuidelOrtho Colloidal Gold Immunochromatography Platform Product Portfolio Table 74. QuidelOrtho Recent Development Table 75. BioMerieux Company Information Table 76. BioMerieux Business Overview Table 77. BioMerieux Colloidal Gold Immunochromatography Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. BioMerieux Colloidal Gold Immunochromatography Platform Product Portfolio Table 79. BioMerieux Recent Development Table 80. Wondfo Company Information Table 81. Wondfo Business Overview Table 82. Wondfo Colloidal Gold Immunochromatography Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Wondfo Colloidal Gold Immunochromatography Platform Product Portfolio Table 84. Wondfo Recent Development Table 85. Celltrion Company Information Table 86. Celltrion Business Overview Table 87. Celltrion Colloidal Gold Immunochromatography Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Celltrion Colloidal Gold Immunochromatography Platform Product Portfolio Table 89. Celltrion Recent Development Table 90. Biomerica Company Information Table 91. Biomerica Business Overview Table 92. Biomerica Colloidal Gold Immunochromatography Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Biomerica Colloidal Gold Immunochromatography Platform Product Portfolio Table 94. Biomerica Recent Development Table 95. Orient Gene Company Information Table 96. Orient Gene Business Overview Table 97. Orient Gene Colloidal Gold Immunochromatography Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Orient Gene Colloidal Gold Immunochromatography Platform Product Portfolio Table 99. Orient Gene Recent Development Table 100. Hotgen Biotech Company Information Table 101. Hotgen Biotech Business Overview Table 102. Hotgen Biotech Colloidal Gold Immunochromatography Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Hotgen Biotech Colloidal Gold Immunochromatography Platform Product Portfolio Table 104. Hotgen Biotech Recent Development Table 105. Easy Diagnosis Biomedicine Company Information Table 106. Easy Diagnosis Biomedicine Business Overview Table 107. Easy Diagnosis Biomedicine Colloidal Gold Immunochromatography Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Easy Diagnosis Biomedicine Colloidal Gold Immunochromatography Platform Product Portfolio Table 109. Easy Diagnosis Biomedicine Recent Development Table 110. Getein Biotech Company Information Table 111. Getein Biotech Business Overview Table 112. Getein Biotech Colloidal Gold Immunochromatography Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Getein Biotech Colloidal Gold Immunochromatography Platform Product Portfolio Table 114. Getein Biotech Recent Development Table 115. Biology and Science Company Information Table 116. Biology and Science Business Overview Table 117. Biology and Science Colloidal Gold Immunochromatography Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Biology and Science Colloidal Gold Immunochromatography Platform Product Portfolio Table 119. Biology and Science Recent Development Table 120. Boson Biotech Company Information Table 121. Boson Biotech Business Overview Table 122. Boson Biotech Colloidal Gold Immunochromatography Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Boson Biotech Colloidal Gold Immunochromatography Platform Product Portfolio Table 124. Boson Biotech Recent Development Table 125. Beijing WANTAI Company Information Table 126. Beijing WANTAI Business Overview Table 127. Beijing WANTAI Colloidal Gold Immunochromatography Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Beijing WANTAI Colloidal Gold Immunochromatography Platform Product Portfolio Table 129. Beijing WANTAI Recent Development Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Colloidal Gold Immunochromatography Platform Product Image Figure 2. Global Colloidal Gold Immunochromatography Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Colloidal Gold Immunochromatography Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Colloidal Gold Immunochromatography Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Naked-Eye Card Reader Platform Image Figure 8. Matching Reader Instrument Platform Image Figure 9. Global Colloidal Gold Immunochromatography Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Colloidal Gold Immunochromatography Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Colloidal Gold Immunochromatography Platform Sales Value Share by Type (2021-2032) Figure 12. Medical Industry Image Figure 13. Food Industry Image Figure 14. Scientific Research Industry Image Figure 15. Others Image Figure 16. Global Colloidal Gold Immunochromatography Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Colloidal Gold Immunochromatography Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Colloidal Gold Immunochromatography Platform Sales Value Share by Application (2021-2032) Figure 19. Global Colloidal Gold Immunochromatography Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Colloidal Gold Immunochromatography Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Colloidal Gold Immunochromatography Platform Sales Value (2021-2032) & (US$ Million) Figure 22. North America Colloidal Gold Immunochromatography Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Colloidal Gold Immunochromatography Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Colloidal Gold Immunochromatography Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Colloidal Gold Immunochromatography Platform Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Colloidal Gold Immunochromatography Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Colloidal Gold Immunochromatography Platform Sales Value (2021-2032) & (US$ Million) Figure 28. South America Colloidal Gold Immunochromatography Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Colloidal Gold Immunochromatography Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Colloidal Gold Immunochromatography Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Naked-Eye Card Reader Platform
  • Matching Reader Instrument Platform
Applications
  • Medical Industry
  • Food Industry
  • Scientific Research Industry
  • Others
Companies covered
  • Abbott
  • Roche
  • Siemens Healthineers
  • BD
  • SD Biosensor
  • Abbott Rapid Diagnostics
  • QuidelOrtho
  • BioMerieux
  • Wondfo
  • Celltrion
  • Biomerica
  • Orient Gene
  • Hotgen Biotech
  • Easy Diagnosis Biomedicine
  • Getein Biotech
  • Biology and Science
  • Boson Biotech
  • Beijing WANTAI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Colloidal Gold Immunochromatography Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Colloidal Gold Immunochromatography Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Colloidal Gold Immunochromatography Platform Market Dynamics
  1. 2.1 Colloidal Gold Immunochromatography Platform Industry Trends
  2. 2.2 Colloidal Gold Immunochromatography Platform Industry Drivers
  3. 2.3 Colloidal Gold Immunochromatography Platform Industry Opportunities and Challenges
  4. 2.4 Colloidal Gold Immunochromatography Platform Industry Restraints
3 Colloidal Gold Immunochromatography Platform Market by Company
  1. 3.1 Global Colloidal Gold Immunochromatography Platform Company Revenue Ranking in 2025
  2. 3.2 Global Colloidal Gold Immunochromatography Platform Revenue by Company (2021-2026)
  3. 3.3 Global Colloidal Gold Immunochromatography Platform Company Ranking (2024-2026)
  4. 3.4 Global Colloidal Gold Immunochromatography Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Colloidal Gold Immunochromatography Platform Company Product Type and Application
  6. 3.6 Global Colloidal Gold Immunochromatography Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Colloidal Gold Immunochromatography Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Colloidal Gold Immunochromatography Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Colloidal Gold Immunochromatography Platform Market by Type
  1. 4.1 Colloidal Gold Immunochromatography Platform Type Introduction
  2. 4.1.1 Naked-Eye Card Reader Platform
  3. 4.1.2 Matching Reader Instrument Platform
  4. 4.2 Global Colloidal Gold Immunochromatography Platform Sales Value by Type
  5. 4.2.1 Global Colloidal Gold Immunochromatography Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Colloidal Gold Immunochromatography Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global Colloidal Gold Immunochromatography Platform Sales Value Share by Type (2021-2032)
5 Colloidal Gold Immunochromatography Platform Market by Application
  1. 5.1 Colloidal Gold Immunochromatography Platform Application Introduction
  2. 5.1.1 Medical Industry
  3. 5.1.2 Food Industry
  4. 5.1.3 Scientific Research Industry
  5. 5.1.4 Others
  6. 5.2 Global Colloidal Gold Immunochromatography Platform Sales Value by Application
  7. 5.2.1 Global Colloidal Gold Immunochromatography Platform Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Colloidal Gold Immunochromatography Platform Sales Value by Application (2021-2032)
  9. 5.2.3 Global Colloidal Gold Immunochromatography Platform Sales Value Share by Application (2021-2032)
6 Colloidal Gold Immunochromatography Platform Regional Value Analysis
  1. 6.1 Global Colloidal Gold Immunochromatography Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Colloidal Gold Immunochromatography Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Colloidal Gold Immunochromatography Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Colloidal Gold Immunochromatography Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Colloidal Gold Immunochromatography Platform Sales Value (2021-2032)
  7. 6.3.2 North America Colloidal Gold Immunochromatography Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Colloidal Gold Immunochromatography Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Colloidal Gold Immunochromatography Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Colloidal Gold Immunochromatography Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Colloidal Gold Immunochromatography Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Colloidal Gold Immunochromatography Platform Sales Value (2021-2032)
  16. 6.6.2 South America Colloidal Gold Immunochromatography Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Colloidal Gold Immunochromatography Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Colloidal Gold Immunochromatography Platform Sales Value Share by Country, 2025 VS 2032
7 Colloidal Gold Immunochromatography Platform Country-level Value Analysis
  1. 7.1 Global Colloidal Gold Immunochromatography Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Colloidal Gold Immunochromatography Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Colloidal Gold Immunochromatography Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Colloidal Gold Immunochromatography Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Colloidal Gold Immunochromatography Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Colloidal Gold Immunochromatography Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Colloidal Gold Immunochromatography Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Colloidal Gold Immunochromatography Platform Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Colloidal Gold Immunochromatography Platform Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Siemens Healthineers
  14. 8.3.1 Siemens Healthineers Company Information
  15. 8.3.2 Siemens Healthineers Business Overview
  16. 8.3.3 Siemens Healthineers Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Siemens Healthineers Colloidal Gold Immunochromatography Platform Product Portfolio
  18. 8.3.5 Siemens Healthineers Recent Developments
  19. 8.4 BD
  20. 8.4.1 BD Company Information
  21. 8.4.2 BD Business Overview
  22. 8.4.3 BD Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BD Colloidal Gold Immunochromatography Platform Product Portfolio
  24. 8.4.5 BD Recent Developments
  25. 8.5 SD Biosensor
  26. 8.5.1 SD Biosensor Company Information
  27. 8.5.2 SD Biosensor Business Overview
  28. 8.5.3 SD Biosensor Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SD Biosensor Colloidal Gold Immunochromatography Platform Product Portfolio
  30. 8.5.5 SD Biosensor Recent Developments
  31. 8.6 Abbott Rapid Diagnostics
  32. 8.6.1 Abbott Rapid Diagnostics Company Information
  33. 8.6.2 Abbott Rapid Diagnostics Business Overview
  34. 8.6.3 Abbott Rapid Diagnostics Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Abbott Rapid Diagnostics Colloidal Gold Immunochromatography Platform Product Portfolio
  36. 8.6.5 Abbott Rapid Diagnostics Recent Developments
  37. 8.7 QuidelOrtho
  38. 8.7.1 QuidelOrtho Company Information
  39. 8.7.2 QuidelOrtho Business Overview
  40. 8.7.3 QuidelOrtho Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 QuidelOrtho Colloidal Gold Immunochromatography Platform Product Portfolio
  42. 8.7.5 QuidelOrtho Recent Developments
  43. 8.8 BioMerieux
  44. 8.8.1 BioMerieux Company Information
  45. 8.8.2 BioMerieux Business Overview
  46. 8.8.3 BioMerieux Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BioMerieux Colloidal Gold Immunochromatography Platform Product Portfolio
  48. 8.8.5 BioMerieux Recent Developments
  49. 8.9 Wondfo
  50. 8.9.1 Wondfo Company Information
  51. 8.9.2 Wondfo Business Overview
  52. 8.9.3 Wondfo Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Wondfo Colloidal Gold Immunochromatography Platform Product Portfolio
  54. 8.9.5 Wondfo Recent Developments
  55. 8.10 Celltrion
  56. 8.10.1 Celltrion Company Information
  57. 8.10.2 Celltrion Business Overview
  58. 8.10.3 Celltrion Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Celltrion Colloidal Gold Immunochromatography Platform Product Portfolio
  60. 8.10.5 Celltrion Recent Developments
  61. 8.11 Biomerica
  62. 8.11.1 Biomerica Company Information
  63. 8.11.2 Biomerica Business Overview
  64. 8.11.3 Biomerica Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biomerica Colloidal Gold Immunochromatography Platform Product Portfolio
  66. 8.11.5 Biomerica Recent Developments
  67. 8.12 Orient Gene
  68. 8.12.1 Orient Gene Company Information
  69. 8.12.2 Orient Gene Business Overview
  70. 8.12.3 Orient Gene Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Orient Gene Colloidal Gold Immunochromatography Platform Product Portfolio
  72. 8.12.5 Orient Gene Recent Developments
  73. 8.13 Hotgen Biotech
  74. 8.13.1 Hotgen Biotech Company Information
  75. 8.13.2 Hotgen Biotech Business Overview
  76. 8.13.3 Hotgen Biotech Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hotgen Biotech Colloidal Gold Immunochromatography Platform Product Portfolio
  78. 8.13.5 Hotgen Biotech Recent Developments
  79. 8.14 Easy Diagnosis Biomedicine
  80. 8.14.1 Easy Diagnosis Biomedicine Company Information
  81. 8.14.2 Easy Diagnosis Biomedicine Business Overview
  82. 8.14.3 Easy Diagnosis Biomedicine Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Easy Diagnosis Biomedicine Colloidal Gold Immunochromatography Platform Product Portfolio
  84. 8.14.5 Easy Diagnosis Biomedicine Recent Developments
  85. 8.15 Getein Biotech
  86. 8.15.1 Getein Biotech Company Information
  87. 8.15.2 Getein Biotech Business Overview
  88. 8.15.3 Getein Biotech Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Getein Biotech Colloidal Gold Immunochromatography Platform Product Portfolio
  90. 8.15.5 Getein Biotech Recent Developments
  91. 8.16 Biology and Science
  92. 8.16.1 Biology and Science Company Information
  93. 8.16.2 Biology and Science Business Overview
  94. 8.16.3 Biology and Science Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Biology and Science Colloidal Gold Immunochromatography Platform Product Portfolio
  96. 8.16.5 Biology and Science Recent Developments
  97. 8.17 Boson Biotech
  98. 8.17.1 Boson Biotech Company Information
  99. 8.17.2 Boson Biotech Business Overview
  100. 8.17.3 Boson Biotech Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Boson Biotech Colloidal Gold Immunochromatography Platform Product Portfolio
  102. 8.17.5 Boson Biotech Recent Developments
  103. 8.18 Beijing WANTAI
  104. 8.18.1 Beijing WANTAI Company Information
  105. 8.18.2 Beijing WANTAI Business Overview
  106. 8.18.3 Beijing WANTAI Colloidal Gold Immunochromatography Platform Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Beijing WANTAI Colloidal Gold Immunochromatography Platform Product Portfolio
  108. 8.18.5 Beijing WANTAI Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst